Menlo Park, CA, United States of America

Stephen Wilson Turner

USPTO Granted Patents = 188 (Patent Applications = 23)

CIPO Patents = 12 (Patent Applications = 3)

EPO Patents = 36 (Patent Applications = 33)

Average Co-Inventor Count = 3.3

ph-index = 54

Forward Citations = 9,860(Granted Patents)

DiyaCoin

= 4.43

Inventors with similar research interests:

Location History:

Palo Alto, CA (US) (2007)
Ithaca, NY (US) (2004 - 2011)
Menlo Park, CA (US) (2005 - 2020)
Kirkland, WA (US) (2015 - 2020)
Eugene, OR (US) (2019 - 2023)
Seattle, WA (US) (2015 - 2024)

Company Filing History:

160 out of 432

Pacific Biosciences of California, Inc.

patents

17 out of 1,521

Cornell Research Foundation Inc.

patents

9 out of 4,731

Juniper Networks, Inc.

patents

4. 1 out of 1

Pacific Biosciense of California, Inc.

patent

5. 1 out of 15,458

University of California

patents

6. 1 out of 1

Pacific Biosciences for California, Inc.

patent

where one patent can have more than one assignee

Years Active: 2004-2025

where 'Filed Patents' based on already Granted Patents

188 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12241122 - Illumination of integrated analytical systems (2025-03-04),

2. 12105310 - Illumination of optical analytical devices (2024-10-01),

3. 12071664 - Optics collection and detection system and method (2024-08-27),

4. 11844666 - Classification of nucleic acid templates (2023-12-19),

5. 11773437 - Systems and methods for selectively addressing sparsely arranged electronic measurement devices (2023-10-03),

6. 11705217 - Sequencing using concatemers of copies of sense and antisense strands (2023-07-18),

7. 11640022 - Illumination of optical analytical devices (2023-05-02),

8. 11584959 - Compositions and methods for selection of nucleic acids (2023-02-21),

9. 11530445 - Methods and compositions for delivery of molecule and complexes to reaction sites (2022-12-20),

10. 11384393 - Integrated illumination of optical analytical devices (2022-07-12),

11. 11272132 - Temporal differential active pixel sensor (2022-03-08),

12. 11214830 - Intermittent detection during analytical reactions (2022-01-04),

13. 11186871 - Articles having localized molecules disposed thereon and methods of producing same (2021-11-30),

14. 11142793 - Nucleic acid sequencing with nanoscale electrode pairs (2021-10-12),

15. 11142792 - Single-molecule nanoFET sequencing systems and methods (2021-10-12),

Title: The Innovative Journey of Stephen Wilson Turner

Introduction:

Stephen Wilson Turner, a prolific inventor based in Menlo Park, CA (US), has made significant contributions in the field of nucleic acid sequencing technologies. With an impressive portfolio of 168 patents, Turner is recognized for his groundbreaking work in the characterization of modified nucleic acids.

Latest Patents:

Among his latest patents is the groundbreaking "Classification of nucleic acid templates" innovation. Turner's method, compositions, and systems offer a unique approach to identifying modified nucleotides within nucleic acid sequences. These modifications include chemically and enzymatically modified bases, abasic sites, non-natural bases, secondary structures, and agents bound to a template nucleic acid.

Another notable patent is "Systems and methods for selectively addressing sparsely arranged electronic measurement devices," which showcases Turner's expertise in circuit design. This invention involves nano-electronic measurement devices on a substrate with specialized functionality and interactions for precise electronic measurements.

Career Highlights:

Turner has held pivotal roles in renowned companies such as Pacific Biosciences of California, Inc. (now known as PacBio) and Juniper Networks, Inc., where he has spearheaded cutting-edge research and development initiatives. His innovative spirit and technical prowess have been instrumental in shaping the future of biotechnology and electronics industries.

Collaborations:

Throughout his career, Turner has collaborated with esteemed professionals in the field, including Jonas Korlach and Paul M Lundquist. These partnerships have led to synergistic efforts in advancing scientific research, fostering a culture of innovation, and driving technological progress.

Conclusion:

Stephen Wilson Turner's remarkable journey as an inventor is characterized by a relentless pursuit of excellence and a commitment to pushing the boundaries of scientific exploration. His pioneering patents and collaborative endeavors stand as a testament to his profound impact on the fields of nucleic acid sequencing and circuit design. Turner's visionary contributions continue to inspire future generations of innovators worldwide.

This text is generated by artificial intelligence and may not be accurate.